Discussion on CardioExchange: Two Trials, Two Anticoagulants, Many Implications

Samuel Goldhaber, Elaine Marie Hylek, and Christian Ruff discuss the ATLAS ACS-TIMI 51 and ADOPT trials. They reflect on the implications of these trials and the possible role for newer anticoagulants in the treatment of ACS patients and for VTE prevention in hospitalized medical patients. See what they have to say then give us your take.

CardioExchange is an online community hosted by the New England Journal of Medicine and Journal Watch and dedicated to improving cardiac patient care. Membership is free for medical professionals.